XM does not provide services to residents of the United States of America.

A
A

AuroraCannabis

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

Reuters - 3 weeks ago

Bank of Montreal, Franco-Nevada, Royal Bank of Canada

CANADA RESEARCH ROUNDUP-Bank of Montreal, Franco-Nevada, Royal Bank of Canada Nov 21 (Reuters) - Securities analysts revised their ratings and price targets on several Canadian companies, including Bank of Montreal, Franco-Nevada and Royal Bank of Canada on Tuesday. HIGHLIGHTS * Bank of Montreal BMO.TO : National Bank of Canada cuts PT to C$120 from C$123 * Farmers Edge Inc FDGE.TO : Raymond James raises to market perform from underperform * Franco-Nevada Corp FNV.TO : CIBC cuts target price to
A
C
C
Reuters - 3 weeks ago

Exchange Income, Kiwetinohk Energy, Loblaw

CANADA RESEARCH ROUNDUP-Exchange Income, Kiwetinohk Energy, Loblaw Nov 16 (Reuters) - Securities analysts revised their ratings and price targets on several Canadian companies, including Exchange Income, Kiwetinohk Energy and Loblaw, on Thursday. HIGHLIGHTS * Exchange Income Corp EIF.TO : RBC cuts target price to C$65 from C$70 * Kiwetinohk Energy Corp KEC.TO : Stifel initiates coverage with buy rating * Loblaw Companies Ltd L.TO : CIBC cuts target price to C$150 from C$152 * Metro Inc MRU.TO :
A
Reuters - 4 weeks ago

U.S. STOCKS Hologic, Blink Charging, Adobe

BUZZ-U.S. STOCKS ON THE MOVE-Hologic, Blink Charging, Adobe Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes gained on Friday as a slide in longer-dated Treasury yields boosted megacap growth stocks, while investors looked forward to key economic data next week for more cues on the monetary policy path.
A
C
H
I
W
A
K
W
U
U
A
Reuters - 4 weeks ago

Aurora Cannabis climbs on higher Q3 revenue

BUZZ-Aurora Cannabis climbs on higher Q3 revenue ** Shares of Canadian pot firm Aurora Cannabis ACB.TO rise 6.56% to C$0.65 ** Company reports Q2 revenue of C$63.4 mln ($45.80 mln), 30% higher than a year earlier, helped by growth in global medical cannabis business ** "Experiencing the benefits of diversification across our cannabis and non-cannab
A
Reuters - 4 weeks ago

Aurora Cannabis Inc reports results for the quarter ended in September - Earnings Summary

Aurora Cannabis Inc reports results for the quarter ended in September - Earnings Summary Aurora Cannabis Inc ACB.TO reported quarterly breakeven results​​ per share for the quarter ended in September. The mean expectation of three analysts for the quarter was for a loss of 4 cents per share. Wall Street expected results to range from -6 cents to -2 cents per share.
A

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.